Results 81 to 90 of about 44,270 (170)

Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors. [PDF]

Neuro Oncol, 2021
He Y, Li J, Koga T, Ma J, Dhawan S, Suzuki Y, Furnari F, Prabhu VV, Allen JE, Chen CC.   +9 more
europepmc   +1 more source

Dopamine D2 receptor [PDF]

Science-Business eXchange, 2011
openaire   +1 more source

Functionally Antagonistic Transcription Factors IRF1 and IRF2 Regulate the Transcription of the Dopamine Receptor D2 Gene Associated with Aggressive Behavior of Weaned Pigs. [PDF]

Biology (Basel), 2022
Zhao J, Gao S, Guo Y, Xu Q, Liu M, Zhang C, Cheng M, Zhao X, Schinckel AP, Zhou B.   +9 more
europepmc   +1 more source

Dopamine D2 receptor [PDF]

Science-Business eXchange, 2009
openaire   +1 more source

Dopamine D2 receptor [PDF]

Science-Business eXchange, 2013
openaire   +1 more source

Developing Photoaffinity Probes for Dopamine Receptor D₂ to Determine Targets of Parkinson's Disease Drugs. [PDF]

ACS Chem Neurosci, 2022
Kim ST, Doukmak EJ, Flax RG, Gray DJ, Zirimu VN, de Jong E, Steinhardt RC.   +6 more
europepmc   +1 more source

Effects of Tall Fescue Endophyte Type and Dopamine Receptor D2 Genotype on Cow-Calf Performance during Late Gestation and Early Lactation. [PDF]

Toxins (Basel), 2021
Wilbanks SA, Justice SM, West T, Klotz JL, Andrae JG, Duckett SK.   +5 more
europepmc   +1 more source

Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers 2020, 12, 2436. [PDF]

Cancers (Basel), 2021
Hu W, Zhang L, Ferri-Borgogno S, Kwan SY, Lewis KE, Cun HT, Yeung TL, Soliman PT, Tarapore RS, Allen JE, Guan X, Lu KH, Mok SC, Au-Yeung CL.   +13 more
europepmc   +1 more source

The Heteromeric Dopamine Receptor D2:D3 Controls the Gut Recruitment and Suppressive Activity of Regulatory T-Cells. [PDF]

Int J Mol Sci
Mora J, Raïch I, Ugalde V, Navarro G, Prado C, Vidal PM, Leal P, Espinoza A, Liu M, Weersma R, Gacesa R, Hermoso MA, Franco R, Pacheco R.   +13 more
europepmc   +1 more source

Overexpression of dopamine receptor D2 promotes colorectal cancer progression by activating the β-catenin/ZEB1 axis.

Cancer Sci, 2021
Lee H, Shim S, Kong JS, Kim MJ, Park S, Lee SS, Kim A.   +6 more
europepmc   +1 more source